Details for 2011162681

Up to date per 01.04.2026

Actions

Title / Product Name

Verfahren und Zusammensetzungen zur Behandlung persistenter Infektionen und Krebs mittels Hemmung des programmierten 1 (PD-1)-Zelltodweges

Status

Deleted

Protection Type

European Patent

(AT-) Application Number

2011162681

EP Publication Number

2397156

E-Number

841129

Language

PCT Number

Publication Date

21.12.2011 A

02.11.2016 B1

Registration Date

02.11.2016

AT Publication Date

15.11.2016

Application Date

08.06.2006

Registration Number

Priorities

08.06.2005

688872 P

IPC

A61K 31/713 20060101AFI20160301BHEP

Maximum Duration of Protection

08.06.2026

Owner

Dana-Farber Cancer Institute, Inc.450 Brookline Avenue02215 Boston, MA US

The Brigham and Women's Hospital, Inc.75 Francis Street02115 Boston, MAUS

Emory University1599 Clifton Road NE, 4th Floor3032 Atlanta, GA US

The President and Fellows of Harvard College17 Quincy Street 02138 Cambridge, MAUS

Representative

Patentanwaltskanzlei Matschnig & Forsthuber OG WIEN

Inventor

Barber, Daniel5440 Marinelli Road, Apt. 206 North Bethesda, MD 20852US

Wherry, E. John110 Myrtie Avenue Havertown, Pennsylvania 19083US

Freeman, Gordan305 Walnut Street Brookline, MA 02445US

Sharpe, Arlene305 Walnut Street Brookline, MA 02445US

Dorfman, David M.42, Welland Road Brookline, MA 02445US

Ahmed, Rafi1811 Durand Mill Drive Atlanta, GA 30307US